Memphis Pharmaceuticals & Chemical Industries reported earnings results for the nine months ended March 31, 2022. For the nine months, the company reported sales was EGP 406.51 million compared to EGP 395.57 million a year ago. Net income was EGP 21 million compared to EGP 25.37 million a year ago.